Clinical Chemistry · 2014 · 47 citations · 30 references
Assessment of a limited number of chromosomal structural instabilities by use of massive parallel sequencing of cfDNA was sufficient to distinguish between prostate cancer and controls. This large cohort demonstrates the utility of cfDNA in prostate cancer recently established in other malignant neoplasms.
30
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman, Scott V. Bratman, Jacqueline To et al. · Nature Medicine · 2014 · 2.2K citations · Full text
Tumor Biology, Oncology, Engineering +14
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah‐Jane Dawson, Dana W.Y. Tsui, Muhammed Murtaza et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text